Aspiriant LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,742
| Closed | -$259K | – | 287 |
|
|
2023
Q2 | $259K | Hold |
2,742
| – | – | 0.01% | 246 |
|
|
2023
Q1 | $227K | Hold |
2,742
| – | – | 0.01% | 258 |
|
|
2022
Q4 | $205K | Buy |
2,742
+23
| +0.8% | +$1.72K | 0.01% | 262 |
|
|
2022
Q3 | $225K | Sell |
2,719
-6
| -0.2% | -$497 | 0.01% | 240 |
|
|
2022
Q2 | $259K | Buy |
+2,725
| New | +$259K | 0.01% | 229 |
|